Medication info

Lubis D Tablet

Prescription medicationApproval withdrawn
Ingredient · strength
Tripotassium Bismuth Dicitrate›Strength being verifiedRanitidine Hydrochloride›Strength being verifiedSucralfate Hydrate›Strength being verified
Manufacturer / importer
Korea Huetex Pharmaceutical Co., Ltd.
Appearance
Light green, rectangular film-coated tablets
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Approval withdrawn

MFDS item code 201905082 · Approved 2019.07.19

This product's status changed to Approval withdrawn on 2023.05.10. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of acid-related disorders (e.g., ulcers and gastritis) and prevention of Mendelson's syndrome before anesthesia
Who uses it
Adults
Adult dosage
○ Adults Usually, take 1 tablet orally twice daily, in the morning and at bedtime, regardless of meals. 1) Gastric and duodenal ulcers Take 1 tablet twice daily or 2 tablets once daily at bedtime. In particular, a higher cure rate may be achieved in patients with duodenal ulcers by taking 2 tablets twice daily, in the morning and at bedtime. The same dosage applies to combination therapy for ulcers caused by nonsteroidal anti-inflammatory drugs (NSAIDs) or to prevent gastric and duodenal ulcers during long-term NSAID therapy. Diseases caused by NSAID administration usually heal within 4 weeks, and ulcers usually heal within 8 weeks; however, healing time may occasionally be prolonged in some patients. For patients with recurrent ulcers who responded well to short-term treatment with this medicine, administer 1 tablet once daily at bedtime as maintenance therapy. 2) Reflux esophagitis For 8 weeks, take 1 tablet twice daily or 2 tablets once daily at bedtime. In patients with severe reflux esophagitis, the dose may be increased to 2 tablets four times daily. 3) Zollinger-Ellison syndrome Start treatment with an initial dose of 1 tablet three times daily and increase the dose as needed. In severe disease, up to 6 g per day of ranitidine may be administered as directed by a physician. 4) Upper gastrointestinal bleeding due to peptic ulcers, acute stress ulcers, and acute gastric mucosal lesions When oral administration becomes possible, switch from injection to oral administration and take 1 tablet twice daily. 5) Premedication for anesthesia (prevention of Mendelson syndrome) Administer 1 tablet 2 hours before induction of anesthesia. It is also preferable to administer 1 tablet on the night before surgery.

Ingredients

Manufacturer
Korea Huetex Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of acid-related disorders (e.g., ulcers and gastritis) and prevention of Mendelson's syndrome before anesthesia

  • Gastric and duodenal ulcers
  • gastritis
  • Zollinger-Ellison syndrome
  • gastroesophageal reflux disease
  • Mendelson's syndrome
  • post-surgical ulcers
  • gastric and duodenal ulcers caused by nonsteroidal anti-inflammatory drugs
View approved original text

This medication is used for gastrointestinal disorders such as gastric and duodenal ulcers, gastritis, and gastroesophageal reflux disease. It is also effective in cases of excessive gastric acid secretion, such as Zollinger-Ellison syndrome. It may be administered to prevent Mendelson's syndrome prior to anesthesia, and it helps treat ulcers that may occur post-surgery. It is also used for gastric and duodenal ulcers caused by nonsteroidal anti-inflammatory drugs (NSAIDs). This drug improves various symptoms and diseases related to excess gastric acid.

Dosage and Administration

Adult dosage

○ Adults Usually, take 1 tablet orally twice daily, in the morning and at bedtime, regardless of meals. 1) Gastric and duodenal ulcers Take 1 tablet twice daily or 2 tablets once daily at bedtime. In particular, a higher cure rate may be achieved in patients with duodenal ulcers by taking 2 tablets twice daily, in the morning and at bedtime. The same dosage applies to combination therapy for ulcers caused by nonsteroidal anti-inflammatory drugs (NSAIDs) or to prevent gastric and duodenal ulcers during long-term NSAID therapy. Diseases caused by NSAID administration usually heal within 4 weeks, and ulcers usually heal within 8 weeks; however, healing time may occasionally be prolonged in some patients. For patients with recurrent ulcers who responded well to short-term treatment with this medicine, administer 1 tablet once daily at bedtime as maintenance therapy. 2) Reflux esophagitis For 8 weeks, take 1 tablet twice daily or 2 tablets once daily at bedtime. In patients with severe reflux esophagitis, the dose may be increased to 2 tablets four times daily. 3) Zollinger-Ellison syndrome Start treatment with an initial dose of 1 tablet three times daily and increase the dose as needed. In severe disease, up to 6 g per day of ranitidine may be administered as directed by a physician. 4) Upper gastrointestinal bleeding due to peptic ulcers, acute stress ulcers, and acute gastric mucosal lesions When oral administration becomes possible, switch from injection to oral administration and take 1 tablet twice daily. 5) Premedication for anesthesia (prevention of Mendelson syndrome) Administer 1 tablet 2 hours before induction of anesthesia. It is also preferable to administer 1 tablet on the night before surgery.

Precautions

It is not safe to use this medication in patients undergoing dialysis or with impaired kidney function. Patients who have had allergic reactions to this drug or its components, a history of acute porphyria, have undergone upper gastrointestinal surgery, are pregnant or potentially pregnant, premature infants, and neonates should also not be administered this medication, as well as patients adhering to a potassium-restricted diet. Care should be taken in patients with compromised liver function, a history of drug allergies, elderly patients, patients with kidney issues, and those taking nonsteroidal anti-inflammatory drugs when using this medication. Especially, as this drug may mask symptoms of gastric cancer, patients with gastric ulcers or middle-aged patients recently experiencing new dyspeptic symptoms should confirm that it is not a malignant condition before treatment. Patients with Helicobacter pylori infection and gastric or duodenal ulcers require treatment to eradicate the bacteria. Patients in severe intensive care units, patients with hypophosphatemia, and those with swallowing difficulties also need to be cautious when administered this medication. During treatment with this medication, rare cases of allergic reactions or shock, skin rash, decreased blood cell counts, liver dysfunction, arrhythmias, gastrointestinal symptoms, neurological symptoms, muscle pain, and hair loss may occur, so if any of these symptoms arise, immediate consultation with medical staff is advised. Long-term use should be avoided, and if the treatment effect is absent, it is advisable to switch to another medication. Elderly patients, patients with chronic lung disease, and patients with diabetes may have an increased risk of pneumonia and should be monitored closely. Avoid driving or operating dangerous machinery if dizziness or drowsiness occurs while taking this medication. This drug may interact with other medications, so it is essential to inform the healthcare provider of any other medications being taken. It is safest for women who are pregnant or breastfeeding to avoid using this drug, and its safety for children has not been established, so administration is not recommended. This medication may affect certain clinical test results, so caution is needed during tests. In case of overdose, treatment such as vomiting or gastric lavage may be necessary, and in severe cases, blood dialysis can be performed. Finally, since this drug decreases gastric acid secretion and can promote bacterial growth in the stomach, regular check-ups, including eye exams, are necessary for long-term use.

Side effects

  • Anaphylactic shock
  • skin rash
  • urticaria
  • angioedema
  • fever
  • bronchospasm
  • hypotension
  • chest pain
  • granulocytopenia
  • leukopenia
Show 57 more
  • thrombocytopenia
  • elevated serum creatinine
  • elevated serum aminotransferases
  • agranulocytosis
  • pancytopenia
  • myelosuppression
  • aplastic anemia
  • aplastic anemia
  • acquired immune hemolytic anemia
  • eosinophilia
  • elevated AST
  • elevated ALT
  • elevated r-GTP
  • elevated ALP
  • cholestatic hepatitis
  • non-cholestatic hepatitis
  • tachycardia
  • bradycardia
  • atrioventricular block
  • premature ventricular contractions
  • arrhythmia
  • vasculitis
  • nausea
  • vomiting
  • constipation
  • diarrhea
  • abdominal distension
  • abdominal pain
  • loss of appetite
  • dizziness
  • drowsiness
  • confusional state
  • seizures
  • agitation
  • insomnia
  • headache
  • heaviness in the head
  • disease sensation
  • anxiety
  • mental confusion
  • depression
  • hallucinations
  • blurred vision
  • involuntary movement disorders
  • altered consciousness
  • myotonic spasms
  • gynecomastia
  • galactorrhea
  • erectile dysfunction
  • decreased libido
  • arthralgia
  • myalgia
  • rhabdomyolysis
  • alopecia
  • stomatitis
  • pruritus
  • acute interstitial nephritis

Not everyone experiences these, and they can vary from person to person.

Storage

Store this medication in a tightly sealed container to prevent exposure to air or moisture, preferably at room temperature between 1 and 30 degrees Celsius. Proper storage will help maintain the drug's effectiveness over time.

Appearance and packaging

Appearance

Light green, rectangular film-coated tablets

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.